title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Tesla, Nvidia, John Wiley & Sons And Other Big Stocks Moving Higher On Thursday - Tesla  ( NASDAQ:TSLA ) ",20240613T141719,https://www.benzinga.com/news/24/06/39313835/tesla-nvidia-john-wiley-sons-and-other-big-stocks-moving-higher-on-thursday,OPTGF,0.096671,Neutral,0.0
Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer,20240611T122000,https://www.globenewswire.com/news-release/2024/06/11/2896777/0/en/Processa-Pharmaceuticals-Announces-Positive-Efficacy-Results-from-Preliminary-Evaluation-of-Phase-1b-Dose-escalating-Trial-with-NGC-Cap-in-Gastrointestinal-Cancer.html,OPTGF,0.031529,Neutral,0.129733
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference,20240328T121500,https://www.globenewswire.com/news-release/2024/03/28/2853979/0/en/Processa-Pharmaceuticals-to-Present-at-the-MedInvest-Biotech-and-Pharma-Investor-Conference.html,OPTGF,0.076115,Neutral,0.140786
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting,20240325T121500,https://www.globenewswire.com/news-release/2024/03/25/2851598/0/en/Processa-Pharmaceuticals-to-Present-Data-at-the-American-Association-for-Cancer-Research-Annual-Meeting.html,OPTGF,0.124809,Neutral,0.141314
Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference,20240221T131500,https://www.globenewswire.com/news-release/2024/02/21/2832738/0/en/Processa-Pharmaceuticals-to-Present-at-the-2024-BIO-CEO-Investor-Conference.html,OPTGF,0.07913,Neutral,0.141687
